HIGHLY CONCENTRATED COMPOSITIONS OF ANTIBODIES TO C5 Russian patent published in 2023 - IPC A61K39/395 A61K9/08 A61K47/18 A61K47/22 A61K47/26 C07K16/18 

Abstract RU 2787595 C2

FIELD: biotechnology.

SUBSTANCE: group of inventions relates to stable aqueous solutions containing an antibody to C5 in a high concentration and methods for the production of these solutions. The stable aqueous solution contains an antibody to C5 at a concentration of 100 mg/ml ± 5%, 50 mM ± 5% of a phosphate buffer, 5% ± 5% of sucrose. In another option, the solution also contains 0.05% ± 5% of polysorbate 80. The antibody to C5 contains a heavy chain with SEQ ID NO: 14 and a light chain with SEQ ID NO: 11. Methods for the treatment or prevention of disorders associated with C5 complement system, such as paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic-uremic syndrome (aHUS), using these solutions, are also proposed. Therapeutic kits containing the specified solution and a means for administration of the solution to a patient who needs treatment are also presented.

EFFECT: invention provides a stable highly concentrated aqueous solution of an antibody to C5, which remains for at least 97% monomeric and preserves at least 90% of its C5-binding activity during storage at 2-8°C for at least six months.

27 cl, 53 dwg, 23 tbl, 3 ex

Similar patents RU2787595C2

Title Year Author Number
DOSES AND ADMINISTRATION OF ANTIBODIES AGAINST C5 FOR TREATMENT OF ATYPICAL HEMOLYTIC UREMIC SYNDROME (aHUS) 2020
  • Pejton, Lori
  • Miks, Kristian
  • Pradkhan, Radzhendra
  • Damokosh, Andryu
  • Svenson, Yudzhin Skott
  • Gao, Syan
RU2822664C2
GM-CSF-NEUTRALIZING ANTIBODIES FOR USE IN TREATING RHEUMATOID ARTHRITIS OR AS ANALGESICS 2014
  • Dr. Wagner Thomas
  • Carlsson Malin
  • Staum Kaltoft Margit
RU2714919C2
ANTIBODIES AGAINST E-SELECTIN, COMPOSITIONS AND METHODS OF USE 2021
  • Apgar, Dzhejms Rizoner
  • Bouli, Sheril Rubio
  • Elvell, Dzhoann Elizabet-Ajriss
  • Lin, Laura
  • Narula, Dzhatin
  • Parng, Chuenlej
  • Pittman, Debra Denene
  • Rakkhe, Svapnil
  • Yuj, Chikhij Vinsent
RU2805176C1
PHARMACEUTICAL COMPOSITION BASED ON ANTIBODIES AGAINST CD40 AND APPLICATION THEREOF 2019
  • Yang, Jianjian
  • Li, Hao
  • Liu, Xun
  • Jiang, Jiahua
RU2778572C1
COMPOSITION CONTAINING ANTIBODY AGAINST ABETA PROTOFIBRILS AND INHIBITOR OF BETA-SECRETASE BACE1 FOR TREATMENT OF ALZHEIMER'S DISEASE 2017
  • Satlin, Andrew
  • Fukushima, Tatsuto
RU2786476C2
STABLE COMPOSITIONS OF ANTI-TIGIT ANTIBODIES, INDIVIDUALLY AND IN COMBINATION WITH ANTIBODIES AGAINST PROGRAMMED DEATH RECEPTOR 1 (PD-1), AND METHODS OF THEIR USE 2018
  • De, Arnab
  • Narasimkhan, Chakravarti Nachu
RU2820576C2
SELECTION OF PATIENTS WITH HEADACHE SUSCEPTIBLE TO ANTIBODIES AGAINST CALCITONIN GENE-RELATED PEPTIDE 2018
  • Burstein, Rami
RU2770066C2
PHARMACEUTICAL COMPOSITION AND METHOD OF PREVENTION AND TREATMENT OF LYSOSOMAL ENZYME DEFICIENCY IN SUBJECT WITH TYPE II MUCOPOLYSACCHARIDOSIS 2023
  • Shukurov Rakhim Rakhmankulyevich
  • Reshetnik Elizaveta Vyacheslavovna
  • Khamitov Ravil Avgatovich
  • Shuster Aleksandr Mikhajlovich
RU2814280C1
PHARMACEUTICAL COMPOSITION OF THE FUSION PROTEIN OF THE TRANSFORMING GROWTH FACTOR BETA RECEPTOR AND ITS APPLICATION 2019
  • Tyan, Chenmin
  • Li, Khao
  • Lyu, Syun
RU2791683C2
COMBINED FORMULATIONS OF ANTI-LAG3 ANTIBODY AND ANTI-PD-1 ANTIBODY 2019
  • Antoshchuk, Valentin
  • Desai, Priti, Dzh.
  • Krishnamakhari, Jogita
  • Sangani, Sakhil, S.
RU2822192C2

RU 2 787 595 C2

Authors

Ortiz, Stephan

Gentile, Jillian

Philominathan, Leena

Routhier, Eric

Mason, Bruce

Dates

2023-01-11Published

2018-07-27Filed